Form 4: Prestige Consumer Healthcare Executive Exercises Options and Sells Shares
SEC Form 4 Filing
Mary Beth Fritz, SVP Quality & Regulatory at Prestige Consumer Healthcare, exercised stock options and sold shares on February 27 and 28, 2024.
Summary
- Mary Beth Fritz, SVP Quality & Regulatory at Prestige Consumer Healthcare Inc., executed multiple transactions involving the company's stock.
- On February 27, 2024, Ms. Fritz exercised options to acquire 1 share at $57.18 and sold 1 share at $70.
- On February 28, 2024, she exercised options to acquire 246 shares at $57.18 and sold 246 shares at a weighted average price of $70.19.
- Also on February 28, 2024, she exercised options to acquire 416 shares at $30.56 and sold 416 shares at a weighted average price of $70.36.
- Following these transactions, Ms. Fritz directly owns 15,934 shares of Prestige Consumer Healthcare Inc.
Sentiment
Score: 5
Explanation: The document reflects routine insider trading activity (exercise of options and sale of shares), which is neither particularly positive nor negative. It's a neutral event in the context of executive compensation.
Positives
- The exercise of stock options indicates confidence in the company's future, as the executive is willing to convert options into shares.
Negatives
- The sale of shares by an executive could be interpreted negatively by some investors, although it is a common practice after exercising options.
Risks
- Executive stock sales can sometimes create short-term downward pressure on the stock price.
Industry Context
Insider trading activity is closely monitored in the consumer healthcare industry to ensure fair market practices and transparency.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are common in publicly traded companies like Prestige Consumer Healthcare.
- The exercise and sale of shares by executives are typical occurrences and are often part of their overall financial planning.
- Companies like Church & Dwight and Reckitt Benckiser also have executives who periodically exercise options and sell shares.
Stakeholder Impact
- The transactions may have a minor, short-term impact on shareholders due to the sale of shares in the open market.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Executive exercised options and sold shares. |
| 02/28/2024 | Executive exercised options and sold shares. |
| 02/29/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.